Different inhibitory potencies of acyclic phosphonomethoxyalkyl nucleotide analogs toward DNA polymerases α, δ, and ε

Molecular Pharmacology

Volumn 49, Issue 6, 1996, Pages 1005-1011

  Kramata, Pavel ^a   Votruba, Ivan ^a   Otová, Berta ^b   Holý, Antonín ^a  

^a INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

9 (2 PHOSPHONOMETHOXYETHYL)ADENINE DIPHOSPHATE; 9 (2 PHOSPHONOMETHOXYETHYL)GUANINE DIPHOSPHATE; DNA POLYMERASE; NUCLEOSIDE ANALOG; NUCLEOTIDE DERIVATIVE; UNCLASSIFIED DRUG; VIRUS DNA;

ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; DRUG DNA INTERACTION; DRUG POTENCY; NONHUMAN; PRIORITY JOURNAL; RAT; VIRUS INFECTION;

ANIMALS; DNA; DNA POLYMERASE II; DNA POLYMERASE III; DNA-DIRECTED DNA POLYMERASE; ENZYME INHIBITORS; KINETICS; NUCLEOTIDES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0029941879     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. De Clercq, E., A. Holý, I. Rosenberg, T. Sakuma, J. Balzarini, and P. C. Maudgal. A novel selective broad-spectrum anti-DNA virus agent. Nature (Lond.) 323:464-467 (1986).
2. Pauwels, R., J. Balzarini, D. Schols, M. Baba, J. Desmyter, I. Rosenberg, A. Holy, and E. De Clercq. Phosphonylmethoxyethyl purine derivates, a new class of anti-human immunodeficiency virus agents. Antimicrob. Agents Chemother. 32:1025-1030 (1988).
3. De Clercq, E. Broad spectrum anti-DNA virus and anti-retrovirus activity of phosphonylmethoxyalkylpurines and -pyrimidines. Biochem. Pharmacol. 42:963-972 (1991).
4. Votruba, I., R. Bernaerts, T. Sakuma, E. De Clercq, A. Merta, I, Rosenberg and A. Holý. Intracellular phosphorylation of broad-spectrum anti-DNA virus agent (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl) adenine and inhibition of viral DNA synthesis. Mol. Pharmacol. 32:524-529 (1987).
5. Balzarini, J., Z. Hao, P. Herdewijn, D. G. Johns, and E. De Clercq. Intracellular metabolism and mechanism of anti-retrovirus action of 9-(2-phosphonylmethoxyethyl) adenine, a potent anti-human immunodeficiency virus compound. Proc. Natl. Acad. Sci. USA 88:1499-1503 (1991).
6. Merta, A., J. Veselý, I. Votruba, I. Rosenberg, and A. Holý Phosphorylation of acyclic nucleotide analogs HPMPA and PMEA in L1210 mouse leukemia cell extracts. Neoplasma 37:111-120 (1990).
7. Merta, A., I. Votruba, J. Jindřich, A. Holý, T. Cihlář, I Rosenberg, M. Otmar, and T. Y. Herve. Phosphorylation of 9-(S)-(3-hydroxy-2-phosphonylmethoxypropy)adenine by AMP (dAMP)kinase from L1210 cells. Biochem. Pharmacol. 44:2067-2077 (1992).
8. Neyts, J., F. Stals, C. Bruggeman, and E. De Clercq. Activity of the anti-HIV agent 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine against cytomegalovirus in vitro and in vivo. Eur. J. Clin., Microbiol. & Infect. Dis. 12:437-446 (1993).
9. Merta, A., I. Votruba, I. Rosenberg, M. Otmar, H. Hřebabecký, R. Bernaèrts, and A. Holý. Inhibition of herpes simplex virus DNA polymerase by diphosphates of acyclic phosphonylmethoxyalkyl nucleotide analogues. Antiviral Res. 13:209-218 (1990).
10. Foster, S. A., J. Černý, and Y.-C. Cheng. Herpes simplex virus-specified DNA polymerase is the target for the antiviral action of 9-(2-phosphonylmethoxyethy)adenine. J. Biol. Chem. 266:238-244 (1991).
11. Votruba, I., M. Trávniček, I. Rosenberg, M. Otmar, A. Merta, H. Hřebabecký, and A. Holý. Inhibition of avian myeloblastosis virus reverse transcriptase by diphosphates of acyclic phosphonylmethyl nucleotide analogues. Antiviral Res. 13:287-294 (1990).
12. Veselý, J., A. Merta, I. Votruba, I. Rosenberg, and A. Holý. The cytostatic effects and mechanism of action of antiviral acyclic adenine nucleotide analogues in L1210 mouse leukemia cells. Neoplasma 37:105-110 (1990).
13. Rose, W. C., A. R. Crosswell, J. J. Bronson, and J. C. Martin. In vivo antitumor activity of 9-[(2-phosphonylmethoxy)ethyl]guannie and related phosphonate nucleotide analogues. J Natl. Cancer Inst. 82:510-512 (1990).
14. Otová, B., M. Sladká, I. Votruba, A. Holý, and V. Křen. Cytostatic effect of 9-(2-phosphonomethoxyethyl)adenine (PMEA). I. Lymphatic leukemia KHP-Lw-I in Lewis rats. Folia Biol. (Prague) 39:136-141 (1993).
15. Otová, B., M. Sladká, K. Blažek, J. Schramlová, I. Votruba, and A. Holý. Cytostatic effect of 9-(2-phosphonomethoxyethyl)adenine (PMEA). II. Lymphoblastic leukemia in Sprague-Dawtey rats. Folia Biol. (Prague) 39:142-149 (1993).
16. Bílá, V., B. Otová, R. Jelínek, M. Sladká, B. Mejsnarová, A. Holý, and V. Křen. Antimitotic and teratogenic effects of acyclic nucleotide analogues 1-(S)-(3-hydroxy-2-phosphonomethoxyethyl)cytosine (HPMPC) and 9-(2-phosphonomethoxyethyl)adenine (PMEA). Folia Biol. (Prague) 39:150-161 (1993).
17. Cherrington, J. M., S. J. Allen, B. H. McKee, and M. S. Chen. Kinetic analysis of the interaction between the diphosphate of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, ddCTP, AZTTP, and FIVUTP with human DNA polymerases β and γ. Biochem. Pharmacol. 48:1986-1988 (1994).
18. Cherrington, J. M., S. J. Allen, N. Bischofberger, and M. S. Chen. Kinetic interaction of the diphosphates of 9-(2-phosphonylmethoxyethyl)adenine and other anti-HIV active purine congeners with HIV reverse transcriptase and human DNA polymerases α, β and γ. Antiviral Chem. Chemother. 6:217-221 (1995).
19. Sambrook, J., E. F. Fritsch, and T. Maniatis. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor. NY (1989).
20. Kramata, P., J. Černý, G. Birkuš, I. Votruba, B. Otová, and A. Holý. DNA polymerases α, δ and ε from T-cell spontaneous lymphoblastic leukemia of Sprague-Dawley inbred rat: isolation and characterization. Collect. Czech. Chem. Commun. 60:1555-1572 (1995).
21. Fien, K., and B. Stillman. Identification of replication factor C from Saccharomyces cerevisiae: a component of the leading-strand DNA replication complex. Mol. Cell. Biol. 12:155-163 (1992).
22. Almendral, I. M., D. Heubsch, P. A. Blundell, H. Mac Donald-Bravo, and R. Bravo. Cloning and sequence of the human nuclear protein cyclin: homology with DNA-binding proteins. Proc. Natl. Acad. Sci. USA 84:1575-1579 (1987).
23. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254 (1976).
24. Waga, S., and B. Stillman. Anatomy of a DNA replication fork revealed by reconstitution of SV 40 DNA replication in vitro. Nature (Lond.) 369:207-212 (1994).
25. Lehman, I. R., and L. S. Kaguni. DNA polymerase α. J. Biol. Chem. 264:4265-4268 (1989).
26. Kunkel, T A., R. D. Sabatino, and R. A. Bambara. Exonucleolytic proof-reading by calf thymus DNA polymerase Sδ. Proc. Natl. Acad. Sci. USA 84:4865-4869 (1987).
27. Sabatino, R. D., T. W. Myers, and R. A. Bambara. Substrate specificity of the exonuclease associated with calf DNA polymerase ε. Cancer Res. 50: 5340-5344 (1990).
28. Araki, H., P. A. Ropp, A. L. Johnson, L. H. Johnston, A. Morrison, and A. Suggino. DNA polymerase II, the probable homolog of mammalian DNA polymerase ε, replicates chromosome DNA in the yeast. Saccharomyces cerevisiae. EMBO J. 11:733-740 (1992).
29. Nethanel, T., and G. Kaufman. Two DNA polymerases may be required for synthesis of the lagging DNA strand of simian virus 40. J. Virol. 64:5912-5918 (1990).
30. Podust, V. N., and U. Hubscher. Lagging strand DNA synthesis by calf thymus DNA polymerases α, β, δ, and ε in the presence of auxiliary proteins. Nucleic Acids Res. 21:841-846 (1993).
31. Turchi, J. J., and R. A. Bambara. Completion of mammalian lagging strand DNA replication using purified proteins. J. Biol Chem. 268:15136-15141 (1993).
32. Nishida, C., P. Reinhard, and S. Linn DNA repair synthesis in human fibroblasts requires DNA polymerase δ. J. Biol. Chem. 263:501-510 (1988).
33. Jessberger, R., V. Podust, U. Hubscher, and P. Berg. A mammalian protein complex that repairs double-strand breaks and deletions by recombination. J. Biol. Chem. 268:1570-1579 (1993).
34. Ng, L , M. McConnell, C.-K. Tan, K. M. Downey, and P. A. Fisher. Interaction of DNA polymerase δ, proliferating cell nuclear antigen and synthetic oligonucleotide template-primers. J. Biol. Chem. 268:13571-13576 (1993).
35. Ilsley, D. D., S.-H. Lee, W. H. Miller, and R. D. Kuchta. Acyclic guanosine analogues inhibit DNA polymerases α, δ, and ε with very different potencies and have unique mechanisms of action. Biochemistry 34:2504-2510 (1995)
36. De Clercq, E., T. Sakuma, M. Baba, R. Pauwels, J. Balzarini, I. Rosenberg, and A. Holý Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines. Antiviral Res 8:261-272 (1987).
37. Pauwels, R., J. Balzarini, D. Schols, M. Baba, P. Desmyter, I. Rosenberg, A. Holý, and E. De Clercq. Phosphonylmethoxyethyl purine derivatives: a new class of anti-HIV agents Antimicrob. Agents Chemother. 32:1025-1030 (1988).
38. Holý, A., E. De Clercq, and I. Votruba Phosphonylmethyl ethers of nucleosides and their acyclic analogues, in Nucleotide Analogues as Antiviral Agents (J. C. Martin, ed.) American Chemical Society, ACS Symposium Series, Washington, D. C., 51-71 (1989).
39. Cihlář, T., I Rosenberg, I. Votruba, and A. Holý. Transport of 9-(2-phosphonomethoxyethy)adenine across plasma membrane of HeLa S3 cells is protein mediated. Antimicrob. Agents Chemother. 39:117-124 (1995).